Home/Filings/4/0001209191-23-030931
4//SEC Filing

Pinion John Richard 4

Accession 0001209191-23-030931

CIK 0001515673other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 1:54 PM ET

Size

5.2 KB

Accession

0001209191-23-030931

Insider Transaction Report

Form 4
Period: 2023-05-18
Transactions
  • Sale

    Common Stock

    2023-05-18$50.00/sh2,012$100,60074,744 total
Footnotes (3)
  • [F1]The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023.
  • [F2]Includes 596 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2023.
  • [F3]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Issuer

Ultragenyx Pharmaceutical Inc.

CIK 0001515673

Entity typeother

Related Parties

1
  • filerCIK 0001648096

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 1:54 PM ET
Size
5.2 KB